Evogene Ltd. current report, Q2 FY2019

Business Context and Reporting Period

This Form 6-K filing by Evogene Ltd. is dated May 14, 2019. The document serves as a notice regarding the company's 2019 Annual General Meeting of Shareholders, scheduled to be held on June 26, 2019, at the company's offices in Rehovot, Israel.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice and does not contain financial statements or performance data.

Material Changes

No material changes to financial performance or operations are reported in this document. The filing focuses solely on the administrative details of the upcoming shareholder meeting.

Guidance, Outlook, and Risks

The document does not contain management commentary, financial guidance, outlook, or specific risk factors. It incorporates by reference the Notice of the Meeting, Proxy Statement, and Form of Proxy Card, which are available on the company's investor relations website.

Key Facts for Investors to Verify

  • The date, time, and location of the 2019 Annual General Meeting (June 26, 2019, at 3:00 p.m. Israel time).
  • The contents of the Proxy Statement (Exhibit 99.2) for details on matters to be voted upon.
  • The availability of the Notice of Meeting and Proxy Card on the company's website.